Related Articles
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells
The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation
Differential effects of calcium antagonists on ABCG2/BCRP-mediated drug resistance and transport in SN-38-resistant HeLa cells
Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status